Clinical Trial

Candida PCR Diagnosis Strategy in Patients From Intensive Care Units

Study acronym: CANDI-PCR
Completed
View on ClinicalTrials.gov →
Summary
The aim of this study is to evaluate the implementation of a new technique for invasive candidiasis diagnosis by PCR. The main objective will be to evaluate the effect of this strategy on the time required to obtain results in patients from intensive care units with suspected systemic invasive candidiasis. This PCR method could allow an antifungal switch to be made earlier, limiting the appearance of resistance and reducing the cost of antifungals for healthcare facilities.
Protocol Amendment History 4 changes
critical Trial completed 2026-08-12
notable Enrollment reduced: 120 -> 48 participants 2026-08-12
notable Primary completion moved earlier: 2025-08-01 -> 2025-04-14 2026-08-12
minor Completion moved earlier: 2025-08-01 -> 2025-04-14 2026-08-12
Trial Details
NCT Number NCT04874441
Lead Sponsor University Hospital, Toulouse
Conditions Candida
Enrollment 48 participants
Start Date 2022-05-19
Primary Completion 2025-04-14 (estimated)
Study Completion 2025-04-14 (estimated)
Updated on ClinicalTrials.gov 2026-08-11